The effect of magnesium on depression and sleep quality and quality of life in postmenopausal wome

Phase 3

Recruiting

Conditions: Condition 1: Depression. Condition 2: Sleep quality.
Depressive episode
Sleep disorder, unspecified
G47.9

Registration Number: IRCT20120718010324N75

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 82

Inclusion Criteria

Women who are 45 to 60 years old.
At least one year has passed since their last period.
Mild and moderate depression based on the Beck questionnaire (score 14 to 28)
Diagnosis of inappropriate sleep quality based on the Pittsburgh questionnaire (scores 6 to 21)

Exclusion Criteria

Having other psychotic disorders such as schizophrenia and active delusions ,Insanity, Bipolar disease, Dementia according to the person's self-report or medical record
Regular use of supplements and minerals, especially magnesium, in the last few months
Having diseases such as kidney disease (the active role of the kidney in magnesium homeostasis) and myasthenia gravis (due to the aggravation of the disease by magnesium) and gastrointestinal disease (diarrhea is a common side effect of magnesium) according to the individual's statement or the medical record.
Planned surgery within the next three months (due to the incomplete continuation of the treatment process)
Using drugs that interfere with magnesium (drugs such as Eltrombopag, Baloxavir, Tetracycline, Marboxil, Demeclocycline, Doxycycline, Minocycline, Oxytetracycline)
The existence of recent crises in life

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression. Timepoint: Before the start of the intervention, one month after the start of the intervention, after the end of the intervention. Method of measurement: Beck depression questionnaire.;Sleep quality and its subdomains. Timepoint: Before the start of the intervention, one month after the start of the intervention, after the end of the intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Quality of life and its subdomains. Timepoint: Before the start of the intervention, after the end of the intervention. Method of measurement: Menopause Quality of Life (MENQOL) questionnaire.